Sleep Monitoring Devices Market - Forecast from 2026 to 2031
Description
Sleep Monitoring Devices Market is projected to expand at a 6.89% CAGR, achieving USD 39.005 billion in 2031 from USD 26.156 billion in 2025.
Sleep monitoring devices encompass a maturing ecosystem of consumer wearables (wristbands, rings, smartwatches), nearables (bedside radar, under-mattress piezo sensors, smart pillows), and clinical-grade PSG-adjacent systems. Core metrics have standardized around actigraphy, photoplethysmography (PPG) heart-rate variability, SpO₂, respiratory effort, body temperature, and, increasingly, EEG-derived sleep staging via dry-electrode headbands or in-ear sensors.
Wearables dominate >85 % of unit volume and ≈70 % of revenue. Oura Ring Gen 3, Whoop 4.0, Fitbit Sense 2/Charge 6, Apple Watch Series 9/Ultra 2, Samsung Galaxy Watch 7, and Garmin Vivosmart/Venu lines now deliver validated sleep-staging accuracy within ±10–12 % of PSG for light/deep/REM classification. Continuous SpO₂ and respiratory-rate tracking have become table stakes, enabling population-level screening for undiagnosed obstructive sleep apnea (estimated prevalence 15–30 % in adults, >80 % undiagnosed).
The primary growth driver remains the convergence of rising sleep-disorder awareness with expanding reimbursement pathways. In the U.S., CMS added limited coverage for certain FDA-cleared wearable-derived sleep diagnostics in 2024, while private payors (UnitedHealthcare, Aetna) now recognize watchPAT-style home sleep apnea testing as Tier 1 evidence. Europe’s DiGA fast-track and NHS Digital Health Technology pathways have similarly opened reimbursement for validated digital sleep therapeutics (Somryst, Sleepio) and companion diagnostics.
Clinical adoption is accelerating fastest in cardiology and neurology. Continuous nocturnal HRV and SpO₂ data are now integrated into remote patient monitoring (RPM) CPT 99457/99458 workflows for heart-failure and post-stroke patients, while epilepsy centers use multimodal wearables for seizure-related sleep fragmentation analysis. Hospital-at-home programs increasingly deploy FDA-cleared nearables (Withings Sleep Analyzer, ResMed NightOwl) to reduce readmission risk.
Consumer segmentation has bifurcated:
Premium tier ($300–550) – Oura, Whoop, Ultrahuman Ring Air, Eight Sleep Pod, focusing on recovery scores, HRV-guided training load, and temperature-regulated bedding integration.
Mass tier ($80–250) – Xiaomi Mi Band 9, Amazfit, Fitbit, emphasizing 14–21 day battery life and basic sleep-stage + SpO₂ tracking.
Accuracy expectations have risen sharply. Independent validation studies (e.g., Stanford, Harvard, KU Leuven) now routinely benchmark consumer devices against PSG, with top performers achieving 82–88 % four-stage (wake/light/deep/REM) Cohen’s kappa versus 90 %+ for medical actigraphy. Manufacturers have responded with hybrid machine-learning models trained on multi-million-night datasets and continuous firmware updates.
Privacy and data ownership are emerging differentiators. Local-on-device processing (Apple S9/SiP, Google Tensor) now enables sleep staging without cloud upload, while subscription-free models (Garmin, Withings) are regaining share against Whoop and Oura’s recurring-fee structures.
In conclusion, the sleep monitoring device market has crossed the inflection point from wellness gadget to clinically actionable tool. Success increasingly hinges on three capabilities: (1) validated accuracy against PSG for sleep apnea and circadian biomarkers, (2) seamless integration into RPM and chronic-disease management workflows with reimbursable data outputs, and (3) defensible privacy architecture in an era of expanding payer and employer access to biometric data. Companies that combine medical-grade sensor fusion with consumer-grade ergonomics and clear regulatory/reimbursement pathways will capture the lion’s share of value as sleep moves from lifestyle metric to standard-of-care vital sign.
Key Benefits of this Report:
Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.
Sleep Monitoring Devices Market Segmentation:
By Product Type
Wearable
Watches And Wrist Bands
Rings
Earbuds
Others
Non-Wearable
Bed Sensors
Bed Side Devices
By Distribution Channel
Online
Offline
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others
Sleep monitoring devices encompass a maturing ecosystem of consumer wearables (wristbands, rings, smartwatches), nearables (bedside radar, under-mattress piezo sensors, smart pillows), and clinical-grade PSG-adjacent systems. Core metrics have standardized around actigraphy, photoplethysmography (PPG) heart-rate variability, SpO₂, respiratory effort, body temperature, and, increasingly, EEG-derived sleep staging via dry-electrode headbands or in-ear sensors.
Wearables dominate >85 % of unit volume and ≈70 % of revenue. Oura Ring Gen 3, Whoop 4.0, Fitbit Sense 2/Charge 6, Apple Watch Series 9/Ultra 2, Samsung Galaxy Watch 7, and Garmin Vivosmart/Venu lines now deliver validated sleep-staging accuracy within ±10–12 % of PSG for light/deep/REM classification. Continuous SpO₂ and respiratory-rate tracking have become table stakes, enabling population-level screening for undiagnosed obstructive sleep apnea (estimated prevalence 15–30 % in adults, >80 % undiagnosed).
The primary growth driver remains the convergence of rising sleep-disorder awareness with expanding reimbursement pathways. In the U.S., CMS added limited coverage for certain FDA-cleared wearable-derived sleep diagnostics in 2024, while private payors (UnitedHealthcare, Aetna) now recognize watchPAT-style home sleep apnea testing as Tier 1 evidence. Europe’s DiGA fast-track and NHS Digital Health Technology pathways have similarly opened reimbursement for validated digital sleep therapeutics (Somryst, Sleepio) and companion diagnostics.
Clinical adoption is accelerating fastest in cardiology and neurology. Continuous nocturnal HRV and SpO₂ data are now integrated into remote patient monitoring (RPM) CPT 99457/99458 workflows for heart-failure and post-stroke patients, while epilepsy centers use multimodal wearables for seizure-related sleep fragmentation analysis. Hospital-at-home programs increasingly deploy FDA-cleared nearables (Withings Sleep Analyzer, ResMed NightOwl) to reduce readmission risk.
Consumer segmentation has bifurcated:
Premium tier ($300–550) – Oura, Whoop, Ultrahuman Ring Air, Eight Sleep Pod, focusing on recovery scores, HRV-guided training load, and temperature-regulated bedding integration.
Mass tier ($80–250) – Xiaomi Mi Band 9, Amazfit, Fitbit, emphasizing 14–21 day battery life and basic sleep-stage + SpO₂ tracking.
Accuracy expectations have risen sharply. Independent validation studies (e.g., Stanford, Harvard, KU Leuven) now routinely benchmark consumer devices against PSG, with top performers achieving 82–88 % four-stage (wake/light/deep/REM) Cohen’s kappa versus 90 %+ for medical actigraphy. Manufacturers have responded with hybrid machine-learning models trained on multi-million-night datasets and continuous firmware updates.
Privacy and data ownership are emerging differentiators. Local-on-device processing (Apple S9/SiP, Google Tensor) now enables sleep staging without cloud upload, while subscription-free models (Garmin, Withings) are regaining share against Whoop and Oura’s recurring-fee structures.
In conclusion, the sleep monitoring device market has crossed the inflection point from wellness gadget to clinically actionable tool. Success increasingly hinges on three capabilities: (1) validated accuracy against PSG for sleep apnea and circadian biomarkers, (2) seamless integration into RPM and chronic-disease management workflows with reimbursable data outputs, and (3) defensible privacy architecture in an era of expanding payer and employer access to biometric data. Companies that combine medical-grade sensor fusion with consumer-grade ergonomics and clear regulatory/reimbursement pathways will capture the lion’s share of value as sleep moves from lifestyle metric to standard-of-care vital sign.
Key Benefits of this Report:
Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.
Sleep Monitoring Devices Market Segmentation:
By Product Type
Wearable
Watches And Wrist Bands
Rings
Earbuds
Others
Non-Wearable
Bed Sensors
Bed Side Devices
By Distribution Channel
Online
Offline
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others
Table of Contents
145 Pages
- 1. EXECUTIVE SUMMARY
- 2. MARKET SNAPSHOT
- 2.1. Market Overview
- 2.2. Market Definition
- 2.3. Scope of the Study
- 2.4. Market Segmentation
- 3. BUSINESS LANDSCAPE
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Porter’s Five Forces Analysis
- 3.5. Industry Value Chain Analysis
- 3.6. Policies and Regulations
- 3.7. Strategic Recommendations
- 4. TECHNOLOGICAL OUTLOOK
- 5. SLEEP MONITORING DEVICES MARKET BY PRODUCT TYPE
- 5.1. Introduction
- 5.2. Wearable
- 5.2.1. Watched And Wrist Bands
- 5.2.2. Rings
- 5.2.3. Earbuds
- 5.2.4. Others
- 5.3. Non-Wearable
- 5.3.1. Bed Sensors
- 5.3.2. Bed Side Devices
- 6. SLEEP MONITORING DEVICES MARKET BY DISTRIBUTION CHANNEL
- 6.1. Introduction
- 6.2. Online
- 6.3. Offline
- 7. SLEEP MONITORING DEVICES MARKET BY GEOGRAPHY
- 7.1. Introduction
- 7.2. North America
- 7.2.1. USA
- 7.2.2. Canada
- 7.2.3. Mexico
- 7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Others
- 7.4. Europe
- 7.4.1. Germany
- 7.4.2. France
- 7.4.3. United Kingdom
- 7.4.4. Spain
- 7.4.5. Others
- 7.5. Middle East and Africa
- 7.5.1. Saudi Arabia
- 7.5.2. UAE
- 7.5.3. Others
- 7.6. Asia Pacific
- 7.6.1. China
- 7.6.2. India
- 7.6.3. Japan
- 7.6.4. South Korea
- 7.6.5. Indonesia
- 7.6.6. Thailand
- 7.6.7. Others
- 8. COMPETITIVE ENVIRONMENT AND ANALYSIS
- 8.1. Major Players and Strategy Analysis
- 8.2. Market Share Analysis
- 8.3. Mergers, Acquisitions, Agreements, and Collaborations
- 8.4. Competitive Dashboard
- 9. COMPANY PROFILES
- 9.1. Sleep Number
- 9.2. Rise Science
- 9.3. Dream
- 9.4. The French Aerospace Lab-ONERA
- 9.5. Motive Inc.
- 9.6. Oxehealth
- 9.7. Eight Sleep
- 9.8. iHealth Labs
- 10. APPENDIX
- 10.1. Currency
- 10.2. Assumptions
- 10.3. Base and Forecast Years Timeline
- 10.4. Key Benefits for the Stakeholders
- 10.5. Research Methodology
- 10.6. Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
